25 Sep 2024 --- Johnson & Johnson (J&J) tries for a third time through its subsidiary Red River Talc to settle thousands of lawsuits related to its talc products and end current and future claims specifically related to ovarian cancer. The healthcare giant is dealing with approximately 61,000 lawsuits and maintains that its products do not cause cancer or contain asbestos. Its latest settlement proposal entails Red River paying claimants an additional US$1.75 billion for a total of US$8 billion over 25 years.
